GLYVAR
LIVE

Serial Number

79391198

Owner

Uniogen Oy

Attorney

Mark E. Olds

Filing Date

Jan 3, 2024

Add to watchlist:

No watchlists yet
View on USPTO

GLYVAR Trademark

Serial Number: 79391198 • Registration: 8163869

GLYVAR is a trademark filed by Uniogen Oy on January 3, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Uniogen Oy (5 trademarks)

Tykistökatu 4

Entity Type: 99

Trademark Details

Filing Date

January 3, 2024

Registration Date

March 10, 2026

Published for Opposition

January 20, 2026

Goods & Services

Scientific research; industrial analysis and research services in the field of diagnostic preparations and biotechnology instrumentation; science and technology services, namely, research in the field of diagnostic assays; scientific laboratory services; analytical research laboratory services in the field of diagnostics; medical research laboratory services; research laboratory services in the field of immunoassay and lectin binding testing; medical research laboratory service, namely, preparation of immunohistological samples for analysis in research laboratories; medical research laboratory service, namely, preparation of biological samples for testing and analysis in research laboratories; platform as a service (PaaS) services featuring computer software platforms for processing and analyzing measurement results of optical readers and immunoassay analyzers, and for carrying out diagnostic result interpretation algorithms; software as a service (SaaS) services featuring software for analyzing and reporting of measurement results from optical readers and immunoassay analyzers, and for carrying out diagnostic result interpretation algorithms; software development, programming and implementation; design and development of computer database software; consultancy services relating to quality control; engineering consultancy relating to testing; rental of laboratory apparatus and instruments; scientific research for medical purposes in the area of cancerous diseases

Diagnostic preparations for medical or veterinary purposes; diagnostic substances for medical use; diagnostic biomarker reagents for medical purposes; biological diagnostic reagents for veterinary use; biological reagents for medical use; diagnostic reagents for medical use; veterinary diagnostic reagents; diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; chemical reagents for medical or veterinary purposes; clinical diagnostic reagents for medical use; medical diagnostic test strips for testing bodily fluids; reagent paper for medical or veterinary purposes; reagents for medical use in connection with analyzers; Diagnostic reagents for veterinary use in connection with analyzers; medical diagnostic reagents and assays for testing of body fluids; reagents and media for medical and veterinary diagnostic purposes; reagents for medical use; immunoassay reagents for medical use

Testing apparatus for testing biochemical agents not for medical purposes; diagnostic apparatus for analyzing nucleic acids, proteins, peptides or glycans, not for medical purposes; scientific research and laboratory apparatus, namely, optical readers with built-in dispensers, and optical readers with or without temperature control; laboratory apparatus and instruments, namely, microplates, fluid dispensers, incubators, and microplate shakers, automated laboratory equipment in the nature of laboratory robots, optical filters for laboratory analyzers and optical readers, the foregoing not for medical use; microplate readers; electronic nonmedical imaging devices for microplate imaging; electronic nonmedical imaging devices for immunoassay test strip imaging; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; nonmedical imaging devices for microplate imaging; nonmedical imaging devices for immunoassay test strip imaging; fluorescence photometers; luminescence analyzers, namely, luminescence photometers; nanoparticle size analysers; optical readers; downloadable and recordable computer software for monitoring and controlling laboratory apparatus and instruments; downloadable and recordable computer software for processing and reporting measurement results of optical readers, nucleic acid analyzers and immunoassay analyzers, and for carrying out result interpretation algorithms; downloadable and recordable computer software for laboratory analyzers and microplate readers for use in medical decision support systems; data processing equipment

Medical and veterinary apparatus and instruments for cancer diagnostics and for distinguishing cancer from benign diseases for diagnostic purposes; medical instruments for protein glycovariant testing; testing apparatus for medical purposes for testing biomarkers for cancer or benign diseases in bodily fluids; apparatus for carrying-out diagnostic tests for medical purposes for testing biomarkers for cancer or benign diseases in bodily fluids; diagnostic, examination, and monitoring equipment; diagnostic apparatus for medical purposes, namely, immunoassay processing and analysis apparatus, lectin binding processing and analysis apparatus; medical diagnostic testing instruments for testing biomarkers for cancer or benign diseases in bodily fluids; medical instruments for infectious disease testing; immunological analysers being medical diagnostic instruments for the analysis of bodily fluids; bodily fluids testing apparatus for medical purposes; medical diagnostic testing instruments for use in immunoassay procedure; diagnostic imaging apparatus for medical use; automated analyzers being medical diagnostic instruments for the analysis of body fluids; medical apparatus for tumour diagnosis

Chemical preparations for scientific purposes; chemical reagents for laboratory use, other than for medical or veterinary use; diagnostic reagents for scientific or research use; diagnostic reagents, other than for medical laboratory use, medical, or veterinary use; diagnostic preparations for scientific or research use; reagents for research purposes; reagents for scientific purposes; Diagnostic reagents for industrial purposes; Chemical reagents for industrial purposes; fluorescent chemical preparations for scientific purposes; Diagnostic reagents for laboratory purposes, other than for medical or veterinary purposes; Chemical reagents for laboratory purposes, other than for medical or veterinary purposes; bacterial preparations, other than for medical and veterinary use; bacteriological preparations, other than for medical and veterinary use; chemicals for use in scientific research, other than for medical or veterinary purposes; biochemical preparations for scientific purposes; biochemicals for in vitro and in vivo scientific use; biological tissue cultures, other than for medical or veterinary purposes; Diagnostic reagents for use with analyzers, other than for medical or veterinary purposes; Diagnostic reagents for use in analytical tests, other than for medical or veterinary purposes; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic preparations, other than for medical or veterinary purposes; Diagnostic immunoassay reagents, other than for medical use; chemical reagents for use in genetic research; cultures of microorganisms, other than for medical and veterinary use; buffer solutions for use in analytical chemistry; radioactive elements for scientific purposes; reference standards being biochemical preparations for scientific use; chemically treated nonmedical test strips for diagnostic purposes; chemical test paper for use with assays; Chemical test paper for use with immunoassays; test paper, chemical; antibodies being reagents for scientific purposes, other than for medical or veterinary use; antibody reagents for scientific purposes; indicators being chemical preparations for scientific use; calibration fluids for nucleic acid analyzers and immunoassay analyzers; chemically treated nonmedical test strips for calibration of laboratory apparatus; calibration fluids for optical readers

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 10, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 10, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 10, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 20, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jan 20, 2026 PUBO
NOTIFICATION PROCESSED BY IB
Jan 15, 2026 GPNX
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 14, 2026 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 31, 2025 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 30, 2025 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 17, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 17, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 17, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 17, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 17, 2025 CNEA
NEW REPRESENTATIVE AT IB RECEIVED
Nov 13, 2025 NREP
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 27, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 27, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 27, 2025 TROA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 29, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 13, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 13, 2025 OPNR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 16, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 16, 2025 GNRT
NON-FINAL ACTION WRITTEN
May 16, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 30, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 30, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 30, 2024 TROA
REFUSAL PROCESSED BY IB
Sep 9, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 16, 2024 RFCS
REFUSAL PROCESSED BY MPU
Aug 16, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 7, 2024 RFCR
NON-FINAL ACTION WRITTEN
Aug 6, 2024 CNRT
ASSIGNED TO EXAMINER
Jul 30, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 24, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 19, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 14, 2024 REPR